Merus competitors and similar companiesClear all
Merus's competitors and similar companies include pixon, Cue Biopharma, Celyad and Oxurion.
 Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. |  pixon Pixon is a company that specializes in the implementation of pharmaceutical processes and systems in a GMP-regulated environment. |  Cue Biopharma Cue Biopharma is an immunotherapy company developing biologics engineered to selectively modulate disease-relevant T cells for the treatment of cancer and autoimmune disease. |  Celyad Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology. |  Oxurion Oxurion (formerly known as ThromboGenics) is a biopharmaceutical company developing treatments to preserve vision in patients with diseases affecting the back of the eye. | |
Founding Date | Founding Date 2003 | Founding Date N/A | Founding Date 2015 | Founding Date 2007 | Founding Date 1991 |
Type | Type Private | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Utrecht, NL HQ Cambridge, US | Locations Visp, CH HQ Mannheim, DE Basel, CH | Locations Cambridge, US HQ | Locations Mont-Saint-Guibert, BE HQ New York, US | Locations Leuven, BE HQ Dublin 8, IE |
Employees | Employees 2251% increase | Employees 393% decrease | Employees 4664% increase | Employees 95 | Employees 785% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 142.9 m | Valuation ($) 21.2 m | Valuation ($) 6 m |
Twitter followers | Twitter followers N/A | Twitter followers N/A | Twitter followers 436 | Twitter followers 2.4 k | Twitter followers 1.2 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 7 | Number of tweets (last 30 days) 3 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 2 | Average likes per tweet (last 30 days) 0.7 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 85.71% | Percentage of tweets with engagement (last 30 days) 66.67% | Percentage of tweets with engagement (last 30 days) N/A |
Employee Rating | Employee Rating 4.2 | Employee Rating 5 | Employee Rating 4.8 | Employee Rating 3.5 | Employee Rating 2 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $1.2m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) €1.1m (FY, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods €612k (FY, 2021) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit €5.8m (FY, 2021) | Gross profit €2m (FY, 2021) |
Net income | Net income N/A | Net income N/A | Net income ($53m) (FY, 2022) | Net income (€26.5m) (FY, 2021) | Net income (€29.6m) (FY, 2021) |
Funding | |||||
Total funding raised | Total funding raised $ 149.3m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 3.9m |
For sources of this data, please see the company profile
View company profiles
pixon
HQ
Visp, CH
Employees
39↓ 3% decrease
Pixon is a company that specializes in the implementation of pharmaceutical processes and systems in a GMP-regulated environment.
View companyCue Biopharma
HQ
Cambridge, US
Employees
46
Cue Biopharma is an immunotherapy company developing biologics engineered to selectively modulate disease-relevant T cells for the treatment of cancer and autoimmune disease.
View companyCelyad
HQ
Mont-Saint-Guibert, BE
Employees
95
Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.
View companyOxurion
HQ
Leuven, BE
Employees
78↑ 5% increase
Oxurion (formerly known as ThromboGenics) is a biopharmaceutical company developing treatments to preserve vision in patients with diseases affecting the back of the eye.
View company